Shi Fu

699 total citations · 1 hit paper
56 papers, 459 citations indexed

About

Shi Fu is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shi Fu has authored 56 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 20 papers in Molecular Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shi Fu's work include Bladder and Urothelial Cancer Treatments (20 papers), Ferroptosis and cancer prognosis (12 papers) and Cancer-related molecular mechanisms research (9 papers). Shi Fu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (20 papers), Ferroptosis and cancer prognosis (12 papers) and Cancer-related molecular mechanisms research (9 papers). Shi Fu collaborates with scholars based in China, United Arab Emirates and United States. Shi Fu's co-authors include Haifeng Wang, Xiaorong Chen, Zhong Wang, Meng Gu, Chong Liu, Jiansong Wang, Ting Luan, Juan Zhou, Huan Xu and Yanbo Chen and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Shi Fu

47 papers receiving 456 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model

2023 89 citations Xiaorong Chen, Shi Fu et al. Journal of Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shi Fu China	12	228	128	128	99	74	56	459
Diya B. Joseph United States	9	202 0.9×	223 1.7×	121 0.9×	50 0.5×	80 1.1×	15	519
Qin Yi China	16	313 1.4×	89 0.7×	130 1.0×	70 0.7×	23 0.3×	42	510
Xiaolong Lin China	11	479 2.1×	192 1.5×	94 0.7×	110 1.1×	25 0.3×	22	712
Takanobu Ubai Japan	11	206 0.9×	82 0.6×	46 0.4×	102 1.0×	59 0.8×	23	433
Xiao Wu China	12	144 0.6×	60 0.5×	47 0.4×	79 0.8×	10 0.1×	47	416
William G. Benson United States	6	260 1.1×	54 0.4×	29 0.2×	185 1.9×	148 2.0×	9	583
Zongqiang Huang China	15	302 1.3×	167 1.3×	217 1.7×	56 0.6×	11 0.1×	55	562
Diping Wang United States	8	445 2.0×	89 0.7×	86 0.7×	44 0.4×	9 0.1×	13	619
Xiaheng Deng China	13	517 2.3×	63 0.5×	458 3.6×	121 1.2×	19 0.3×	33	682

Countries citing papers authored by Shi Fu

Since Specialization

Citations

This map shows the geographic impact of Shi Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Fu more than expected).

Fields of papers citing papers by Shi Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Fu. The network helps show where Shi Fu may publish in the future.

Co-authorship network of co-authors of Shi Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Shi Fu. A scholar is included among the top collaborators of Shi Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi Fu. Shi Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Junhao, et al.. (2025). Comprehensive Mendelian randomization and colocalization analysis of plasma proteomics to identify new therapeutic targets for bladder cancer. Journal of Cancer. 16(10). 3163–3179. 1 indexed citations

Zhou, Yueting, et al.. (2025). A study on predicting recurrence of non-muscle-invasive bladder cancer within 2 years using mp-MRI radiomics. BMC Cancer. 25(1). 1497–1497.

Chen, Xiaorong, et al.. (2025). Integrative multi-omics and machine learning identify a robust signature for discriminating prognosis and therapeutic targets in bladder cancer. Journal of Cancer. 16(5). 1479–1503. 1 indexed citations

Fu, Shi, et al.. (2024). A computed tomography urography‐based machine learning model for predicting preoperative pathological grade of upper urinary tract urothelial carcinoma. Cancer Medicine. 13(1). e6901–e6901. 6 indexed citations

Fu, Shi, Zhi‐Yong Tan, Junhao Chen, et al.. (2024). Development of a stemness-related prognostic index to provide therapeutic strategies for bladder cancer. npj Precision Oncology. 8(1). 14–14. 9 indexed citations

Li, Peng, Shi Fu, Jiansong Wang, et al.. (2024). Comparison of the efficacy and safety of mini-percutaneous nephrolithotomy versus retrograde intrarenal surgery for the treatment of kidney stones in overweight or obese patients: a systematic review and meta-analysis. BMC Urology. 24(1). 243–243. 2 indexed citations

Chen, Xiaorong, et al.. (2024). HES4 is a potential biomarker for bladder cancer: a Mendelian randomization study. Journal of Cancer. 15(6). 1624–1641. 2 indexed citations

Chen, Junhao, et al.. (2024). A commentary on ‘causal effects of gut microbiota on renal tumor: a Mendelian randomization study’ (Int J Surg 2024 Jan 15; Online ahead of print.). International Journal of Surgery. 110(6). 3972–3973.

Yang, Zhao, Shi Fu, Yongchao Li, et al.. (2023). Exosome as non-invasive prognostic and diagnostic biomarker and nanovesicle for targeted therapy of non-small cell lung carcinoma. Chemical Engineering Journal. 480. 148160–148160. 12 indexed citations

10.

Fu, Shi, et al.. (2023). Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer. Aging. 15(16). 8384–8407. 4 indexed citations

11.

Chen, Xiaorong, et al.. (2023). Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. Journal of Translational Medicine. 21(1). 223–223. 89 indexed citations breakdown →

12.

Chen, Zihan, Ying Wang, Tao Song, et al.. (2023). Integrated analysis of FKBP1A/SLC3A2 axis in everolimus inducing ferroptosis of breast cancer and anti-proliferation of T lymphocyte. International Journal of Medical Sciences. 20(8). 1060–1078. 8 indexed citations

13.

Chen, Xiaorong, et al.. (2023). Integrating Bulk and Single-Cell RNA Sequencing Reveals Heterogeneity, Tumor Microenvironment, and Immunotherapeutic Efficacy Based on Sialylation-Related Genes in Bladder Cancer. Journal of Inflammation Research. Volume 16. 3399–3417. 2 indexed citations

14.

Fu, Shi, et al.. (2023). Retroperitoneal capillary hemangioma: A case report and literature review. Asian Journal of Surgery. 46(11). 4881–4882. 1 indexed citations

15.

Fu, Shi, et al.. (2022). Identification of Potential Biomarkers for Progression and Prognosis of Bladder Cancer by Comprehensive Bioinformatics Analysis. Journal of Oncology. 2022. 1–17. 6 indexed citations

16.

Chen, Zhenjie, Shi Fu, Haifeng Wang, et al.. (2022). Hsa_circ_0102485 inhibits the growth of cancer cells by regulating the miR-188–3p/ARID5B/AR axis in prostate carcinoma. Pathology - Research and Practice. 237. 154052–154052. 1 indexed citations

17.

Li, Xiaotao, et al.. (2021). Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer. BMC Cancer. 21(1). 1267–1267. 11 indexed citations

18.

Huang, Lijuan, Ting Luan, Yujin Chen, et al.. (2018). LASS2 regulates invasion and chemoresistance via ERK/Drp1 modulated mitochondrial dynamics in bladder cancer cells. Journal of Cancer. 9(6). 1017–1024. 18 indexed citations

19.

Xiao, Chijie, Z. Y. Pu, Zhiwei Ma, et al.. (2005). Cluster Measurements of Fast Magnetic Reconnection in Earth's Magnetotail. AGUFM. 2005. 1 indexed citations

20.

Fu, Shi. (2000). L-Fuzzy Mapping of L-Fuzzy Sets. Mohu xitong yu shuxue. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact